The Easton Regional Cancer Center is accredited by the American College of Surgeons Commission on Cancer, a certification that is only achieved by one in every four hospitals that treat cancer. We are also a member of the Sidney Kimmel Cancer Network at Jefferson.
Breast Care Nurse Navigator
Our breast care nurse navigator works closely with radiologists who specialize in mammography and with others who offer breast biopsy, breast surgery, chemotherapy, radiation therapy and rehabilitative services.
-
provide guidance, education and support to assist you in making informed decisions
-
coordinate aspects of your care, including making timely appointments with breast specialists
-
connect you to resources in the hospital and community
-
assist communication between you and your physicians
- refer you to second-opinion services, as necessary or requested
Tumor Registry
In 1946, Easton Hospital created the nation’s first cancer/tumor registry. The Charles A. Waltman Tumor Registry is an information system that collects, manages and analyzes information on patients with a diagnosis of cancer. The type of information collected and analyzed include demographics, medical history, diagnostic findings and information about specific cancers. The registry also tracks the types and frequency of treatments or interventions that each patient receives and follows cancer survivors for the rest of their lives.
By collecting and analyzing data in cooperation with state and national public health officials, we monitor cancer incidences in our community and identify areas where interventions such as educational programs or screenings are needed. At the community level, we use the registry data to assure that the care offered by the hospital not only meets the needs of the community, but also meets or exceeds the national standards set by the various accrediting agencies for quality care.
Tomotherapy
Easton Hospital is the third healthcare facility in the state of Pennsylvania to offer TomoTherapy, IMRT/IGRT technology for the treatment of many different types of cancer. The TOMOTHERAPY system combines intensity modulated radiation therapy (IMRT), the CT scanning technology (IGRT) and other tools for planning and delivering radiation therapy in one machine.
With TomoTherapy, the radiation therapy team at Easton Regional Cancer Center can:
-
Sculpt small, powerful and precise radiation beams to hit hard to reach tumors
-
Target tumors using built in CT scanning to confirm the shape and position of the tumor seconds before your treatment begins
-
Reduce radiation exposure to healthy surrounding tissue, often dramatically.
If you have reached your maximum tolerance dose of traditional radiation, TomoTherapy may open new doors to advanced radiation therapy treatments.
Resources
Clinical Trials
Our volunteer patients have helped prove that certain drug regimens are more effective and/or better tolerated than others in preventing cancer recurrence. If you are interested in participating in a clinical trial, we encourage you to talk to your physician about the options. Easton Hospital is a member of the NCI CIRB Initiative (National Cancer Institute Central Institutional Review Board). The Central IRB (CIRB) Initiative is designed to help reduce the administrative burden on local IRBs and investigators while continuing a high level of protection for human research participants. The CIRB Initiative is sponsored by NCI in consultation with the Department of Health and Human Services Office for Human Research Protections (OHRP).
The Cancer Support Community of the Greater Lehigh Valley
The Cancer Support Communitys programs help people affected by cancersurvivors, caregivers, friends and family–regain control of their lives, reduce stress and isolation, and restore a sense of hope for a better quality of life regardless of the stage of the disease or the type of cancer.
Leukemia and Lymphoma Society – Lehigh Valley Chapter
The Leukemia & Lymphoma Society (LLS) is the largest voluntary health organization dedicated to funding research, finding cures and ensuring access to treatments for blood cancer patients.